跳至主要内容
临床试验/ACTRN12619001045101
ACTRN12619001045101已完成未知

Exercise and diet for people with hip osteoarthritis who are overweight or obese: the ECHO feasibility study

The University of Melbourne0 个研究点目标入组 18 人开始时间: 2019年7月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 80 Years(—)
性别
All

入选标准

  • i) meet the American College of Rheumatology clinical and radiological criteria for hip osteoarthritis including:
  • a) aged between 50 and 80 years old
  • b) pain in the groin or hip region on most days of the past month
  • c) joint space narrowing and femoral or acetabular osteophytes on x-ray;
  • ii) report history of hip or groin pain for longer than 3 months;
  • iii) report a minimum hip/groin pain score of 4 on an 11-point numeric rating scale during walking over the previous week;
  • iv) have a body mass index (BMI) between 28 kg/m2 and 41 kg/m2;
  • iii) report a stable weight (less than a 2 kg change over the previous 3 months);
  • v) able to give informed consent and to participate fully in the intervention and assessment procedures;
  • vi) willing/able to use the internet for video consultations with the dietitian and physiotherapist; and
  • vii) have ability to weigh themselves

排除标准

  • :i) inability to speak English;
  • ii) on waiting list for or planning spinal/lower limb surgery in next 12 months;
  • iii) previous arthroplasty on affected hip;
  • iv) recent hip surgery (past 6 months);
  • v) self-reported inflammatory arthritis (e.g. rheumatoid arthritis);
  • vi) any neurological condition affecting lower limbs; viii) inability to safely participate in moderate-intensity exercise as determined by the Exercise and Sports Science Australia pre-exercise screening form.
  • vii) unable to undertake very low calorie/ketogenic diet for medical reasons including self-reported:
  • a) diagnosis of Type 1 diabetes;
  • b) Type 2 diabetes requiring insulin or other medication apart from metformin;
  • c) warfarin use;
  • d) stroke or cardiac event in previous 6 months;
  • e) unstable cardiovascular condition;
  • f) fluid intake restriction;
  • g) renal (kidney) problems (an eGFR of <30 mL/min/1.73m2);

研究者

相似试验